Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2021 2
2022 4
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Lupus Nephritis: Improving Treatment Options.
Kostopoulou M, Pitsigavdaki S, Bertsias G. Kostopoulou M, et al. Among authors: pitsigavdaki s. Drugs. 2022 May;82(7):735-748. doi: 10.1007/s40265-022-01715-1. Epub 2022 Apr 29. Drugs. 2022. PMID: 35486369 Review.
Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study.
Nikoloudaki M, Nikolopoulos D, Koutsoviti S, Flouri I, Kapsala N, Repa A, Katsimbri P, Theotikos E, Pitsigavdaki S, Pateromichelaki K, Bertsias A, Elezoglou A, Sidiropoulos P, Fanouriakis A, Boumpas D, Bertsias G. Nikoloudaki M, et al. Among authors: pitsigavdaki s. Front Immunol. 2023 Jan 4;13:1074044. doi: 10.3389/fimmu.2022.1074044. eCollection 2022. Front Immunol. 2023. PMID: 36685524 Free PMC article.
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression.
Pitsigavdaki S, Nikoloudaki M, Garantziotis P, Silvagni E, Repa A, Marangoni A, Flouri I, Avgoustidis N, Parperis K, Fanouriakis A, Govoni M, Sidiropoulos P, Boumpas DT, Bortoluzzi A, Bertsias G. Pitsigavdaki S, et al. Ann Rheum Dis. 2024 Mar 12;83(4):464-474. doi: 10.1136/ard-2023-224919. Ann Rheum Dis. 2024. PMID: 38233103 Free PMC article.
Lower lobe pneumonia presenting as singultus (hiccups).
Karakonstantis S, Pitsigavdaki S, Korela D, Galani D. Karakonstantis S, et al. Among authors: pitsigavdaki s. Caspian J Intern Med. 2018 Fall;9(4):403-405. doi: 10.22088/cjim.9.4.403. Caspian J Intern Med. 2018. PMID: 30510657 Free PMC article.
Comorbidities Burden and Implementation of the Treat-to-Target Strategy in Predicting Real-World Patient Outcomes in Spondyloarthritides.
Flouri ID, Repa A, Avgoustidis N, Pitsigavdaki S, Pateromichelaki K, Marolachaki E, Terizaki M, Nikoloudaki M, Eskitzis A, Kalogiannaki E, Bertsias G, Sidiropoulos P. Flouri ID, et al. Among authors: pitsigavdaki s. Mediterr J Rheumatol. 2023 Jul 31;34(4):581-587. doi: 10.31138/mjr.310723.cba. eCollection 2023 Dec. Mediterr J Rheumatol. 2023. PMID: 38282943 Free PMC article.
Atypical Presentation of IgA Nephropathy Mimicking Acute Pyelonephritis.
Karakonstantis S, Galani D, Korela D, Pitsigavdaki S, Kassotaki I, Arna D, Xydakis D. Karakonstantis S, et al. Among authors: pitsigavdaki s. Case Rep Med. 2018 Jun 13;2018:9231989. doi: 10.1155/2018/9231989. eCollection 2018. Case Rep Med. 2018. PMID: 30008750 Free PMC article.
Correction: Nikoloudaki et al. Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. J. Clin. Med. 2022, 11, 4316.
Nikoloudaki M, Repa A, Pitsigavdaki S, Sali AMI, Sidiropoulos P, Lionis C, Bertsias G. Nikoloudaki M, et al. Among authors: pitsigavdaki s. J Clin Med. 2022 Dec 28;12(1):227. doi: 10.3390/jcm12010227. J Clin Med. 2022. PMID: 36615195 Free PMC article.
12 results